Skip to main content

Abstract

Two melanoma cell lines, SK-MEL-28 and 518 A2 were incubated for different time intervals up to 180 minutes at 37°C. With 99mTc-furifosmin, an uptake of 2%–3% was achieved almost immediately without any significant further change thereafter for a total monitoring period of 180 minutes. In contrast, the 99mTc-tetrofosmin-uptake (about 3%) was comparable up to about 60 minutes showing thereafter a significant (p<0.01) increase. These findings indicate that the kinetics and uptake mechnisms of these two tracers might be different. Thus, it needs to be further elucidated whether the increased late uptake of 99mTc-tetrofosmin might be relevant to be considered for clinical imaging protocols.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Arbab AS, Koizumi K, Toyama K, Araki T. Uptake of technetium-99-tetrofosmin, technetium-99m-MIBI and thallium-201 in tumor cell lines. J Nucl Med 37: 1551–1556, 1996.

    PubMed  CAS  Google Scholar 

  2. Ballinger JR, Bannerman J, Boxen I et al. Technetium-99m-tetrofosmin as a substrate for P-glycoprotein: in-vitro studies in multi-drug resistant breast tumor cells. J Nucl Med 37: 1578–1582, 1996.

    PubMed  CAS  Google Scholar 

  3. Matnusnari I, Kinuya S, Nishikawa T et al. Technetium-99m-tetrofosmin uptake in lung cancer: comparison with thallium-201. Ann Nucl Med 10: 143–145, 1996.

    Article  Google Scholar 

  4. Lind P, Gallowitsch HJ. The use of non-specific tracers in the follow-up of differentiated thyroid cancer: results with Tc-99m-tetrofosmin whole body scintigraphy. Acta Med Austriaca 23: 69–75, 1996.

    PubMed  CAS  Google Scholar 

  5. Schrier PI, Versteeg R, Peltenburg LTC, Plomp AC, Van’t Veer LJ, Kruse-Wolters KM. Sensitivity of melanoma cell lines to natural killer cells: a role for oncogene-modulated HLA class I expression? Semin Cancer Biol 2: 73–83, 1991.

    PubMed  CAS  Google Scholar 

  6. Versteeg R, Peltenburg LTC, Plomp AC, Schrier PI. High expression of the c-myc oncogene renders melanoma cells prone to lysis by natural killer cells. J Immunol 143: 4331–4337, 1989.

    PubMed  CAS  Google Scholar 

  7. Jansen B, Inou SA, Wadl H, Eichler HJ, Wolf K, Van Elsas A, Schrier P, Pehamberger H. N-ras oncogene expression changes the growth characteristics of human melanoma in two independent SCID-hu mouse models. Int J Cancer, 67: 821–825, 1996.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1999 Springer Basel AG

About this paper

Cite this paper

Susan, M. et al. (1999). 99mTc-Furifosmin Uptake by Melanoma Cells. In: Bergmann, H., Köhn, H., Sinzinger, H. (eds) Radioactive Isotopes in Clinical Medicine and Research XXIII. Advances in Pharmacological Sciences. Birkhäuser, Basel. https://doi.org/10.1007/978-3-0348-8782-3_26

Download citation

  • DOI: https://doi.org/10.1007/978-3-0348-8782-3_26

  • Publisher Name: Birkhäuser, Basel

  • Print ISBN: 978-3-0348-9772-3

  • Online ISBN: 978-3-0348-8782-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics